Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

ASCO 2018: Abiraterone may be more effective in black men with advanced prostate cancer than in white men

ASCO 2018: Abiraterone may be more effective in black men with advanced prostate cancer than in white men

ASCO 2018: Penn-led trial shows AZEDRA can be effective, safe for treatment of rare neuroendocrine tumours

ASCO 2018: Penn-led trial shows AZEDRA can be effective, safe for treatment of rare neuroendocrine tumours

Caseload volume in gynaecologic surgery important consideration for women

Caseload volume in gynaecologic surgery important consideration for women

Olfactory receptor as therapeutic target in bladder cancer

Olfactory receptor as therapeutic target in bladder cancer

European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk advanced renal cell carcinoma

European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk...

Queen's University researchers in collaboration to develop a new treatment for pancreatic cancer

Queen's University researchers in collaboration to develop a new treatment for pancreatic cancer

Study picks out children with incurable brain cancer who could benefit from adult therapy

Study picks out children with incurable brain cancer who could benefit from adult therapy

Study hints at new target to improve immune therapy in triple-negative breast cancer

Study hints at new target to improve immune therapy in triple-negative breast cancer

Researchers uncover up to 100 potential drug targets for cancer

Researchers uncover up to 100 potential drug targets for cancer

The most accurate risk prediction models for selecting whom to screen for lung cancer

The most accurate risk prediction models for selecting whom to screen for lung cancer

More from ecancer